Home » Lannett Receives FDA Approval for Triamterene With Hydrochlorothiazide 37.5/25mg Capsules
Lannett Receives FDA Approval for Triamterene With Hydrochlorothiazide 37.5/25mg Capsules
Lannett Company has received approval from the FDA of its abbreviated new drug application for triamterene with hydrochlorothiazide 37.5/25mg capsules.
The Street
The Street
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May